Lmito develops a novel therapy for autoimmune disorders through a modulation of immunometabolism including a macrophage polarization. In the fibrotic context, LMT compounds exert the anti-fibrotic effects through metabolic reprogramming of profibrotic cells in PF-ILD and IPF.
